Analysis: How Medicaid Cuts in ‘Big Beautiful Bill’ Could Push Certain Hospitals Out of 340B and the Importance of Planning Ahead

Experts warn that recently enacted Medicaid cuts could jeopardize some hospitals' 340B eligibility.
Although President Donald Trump’s nearly 900-page “big beautiful bill” never mentions the 340B program, experts warn that the new law’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Matsui, Welch Reintroduce 340B PATIENTS Act in Congress During 340B Coalition Summer Conference

U.S. Rep. Doris Matsui (D-Calif.) and U.S. Sen. Peter Welch (D-Vt.) reintroduced the 340B PATIENTS Act during the 340B Coalition annual summer conference.
The two congressional Democrats behind the 340B PATIENTS Act—a 2024 federal bill that would’ve codified providers’ ability to use 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

OPA Director Touches on 340B Rebate Litigation and Other Key Matters at 340B Coalition Conference

Office of Pharmacy Affairs (OPA) Director Chantelle Britton addresses 340B stakeholders during remarks to open the 340B Coalition’s annual summer conference in National Harbor, Md. on Monday.
A key federal regulator highlighted the Health Resources and Services Administration’s (HRSA) legal fight against proposed drugmaker 340B rebate models [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B PATIENTS Act Reintroduction Expected Soon, Hospital Trade Group Challenges Drug Industry Criticisms

340B Health President and CEO Maureen Testoni speaks at the 340B Coalition's Summer Conference in National Harbor, Md. on Monday.
The leader of a major 340B hospital trade group heralded the forthcoming reintroduction of a federal bill that would codify [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Court Consolidates Drugmaker 340B Rebate Appeals, Denies Hospital Group’s Cross-Appeal Request

A federal appeals court in Washington, D.C. consolidated multiple drugmaker appeals in ongoing 340B rebate litigation.
A Washington, D.C. federal appellate court on Friday consolidated multiple drug industry appeals challenging the government’s authority to preapprove 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK Exempts New States from 340B Contract Pharmacy Restrictions, Teva Issues New Update on Restricted Drugs

GSK and Teva recently announced new changes to their 340B contract pharmacy restrictions.
Two major drugmakers announced new changes to their 340B contract pharmacy restrictions in notices posted to 340B ESP’s website late [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly, Indivior, Kedrion to Refund 340B Covered Entities for Overcharges, Others Announce NDC Changes

Three drugmakers recently announced refunds to 340B covered entities, while two others announced NDC changes.
Three drugmakers are offering refunds to 340B covered entities that purchased certain drugs between 2022 and 2025 following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

For the First Time, CMS Proposes Claims-Based Methods to Identify 340B Drugs Billed to Medicare Part D

CMS recently proposed two policies for identifying 340B claims billed to Medicare Part D.
In a first for the agency, the Centers for Medicare and Medicaid Services (CMS) is proposing to track 340B drugs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Advocates Warn New CMS Proposed Rule Could Hurt 340B Program, Be ‘First Step Towards Payment Cuts’

Hospital groups and other 340B backers condemned proposals, which CMS included in its 900-plus page draft hospital outpatient prospective payment system and ambulatory surgical center rule released this week.
340B hospital advocates are raising concerns that a new Trump administration proposal to accelerate hospital outpatient payment cuts to offset [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

CMS Proposes Accelerated OPPS Cuts to Offset 340B Remedy Payments and Medicare Drug Survey That Could Lead to Significant Part B Cuts

CMS has issued a draft 2026 Hospital Outpatient Prospective Payment System (OPPS) rule, which proposes accelerated cuts to offset 340B remedy payments. The agency also proposed a controversial Medicare drug survey.
The Trump administration this week proposed accelerating hospital outpatient payment cuts to offset previous 340B hospital lump sum repayments and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live